Have a personal or library account? Click to login
The Role of Pharmacists in Enhancing Mental Healthcare in South Africa: A Narrative Review Cover

The Role of Pharmacists in Enhancing Mental Healthcare in South Africa: A Narrative Review

Open Access
|Nov 2025

References

  1. Akour, A., Halloush, S., Nusair, M. B., Barakat, M., Abdulla, F., & Al Momani, M. (2022). Gaps in pharmaceutical care for patients with mental health issues: A cross-sectional study. International journal of clinical pharmacy, 44(4), 904–913. https://doi.org/10.1007/s11096-022-01391-x
  2. Alanazi, M., Ansari, M., & Alharby, T. N. (2024). Community pharmacists’ role towards preventing abuse or misuse and dependence of codeine-containing analgesic medications in Saudi Arabia: a multicenter cross-sectional study. Frontiers in Pharmacology, 15, 1408024.
  3. Almeman, A. (2024). The digital transformation in pharmacy: embracing online platforms and the cosmeceutical paradigm shift. Journal of Health, Population and Nutrition, 43(1), 60. https://doi.org/10.1186/s41043-024-00550-2
  4. Baethge, C., Goldbeck-Wood, S., & Mertens, S. (2019). SANRA—a scale for the quality assessment of narrative review articles. Research integrity and peer review, 4, 1–7. https://doi.org/10.1186/s41073-019-0064-8
  5. Bamgboye, A. O., Hassan, I. A., Adebisi, Y. A., Farayola, R. O., & Uwizeyimana, T. (2021). Towards improving community pharmacy-based mental health services in Nigeria. Journal of Pharmaceutical Policy and Practice, 14(1), 34. https://doi.org/10.1186/s40545-021-00316-9
  6. Barrett, M., Ward, S., & Colvard, M. (2020). Pharmacist-led telemental health transitions of care clinic improves antidepressant medication continuity posthospitalization. Mental Health Clinician, 10(6), 381–384. https://doi.org/10.9740/mhc.2020.11.381
  7. Barron, P., Peter, J., LeFevre, A. E., Sebidi, J., Bekker, M., Allen, R., ... & Pillay, Y. (2018). Mobile health messaging service and helpdesk for South African mothers (MomConnect): history, successes and challenges. BMJ global health, 3(Suppl 2), e000559. https://doi.org/10.1136/bmjgh-2017-000559
  8. Baumeister, R. F., & Leary, M. R. (1997). Writing narrative literature reviews. Review of general psychology, 1(3), 311–320.
  9. Bazzari, A. H., & Bazzari, F. H. (2023). Assessing Stigma towards Mental Illness in Relation to Demographics Attitudes and Past Experiences among Pharmacy Students in a Jordanian University Sample. Behavioral Sciences, 13(11), 884. https://doi.org/10.3390/bs13110884
  10. Bjornestad, J., Davidson, L., Joa, I., Larsen, T. K., Hegelstad, W. T. V., Langeveld, J., ... & Bronnick, K. (2017). Antipsychotic treatment: experiences of fully recovered service users. Journal of Mental Health, 26(3), 264–270. https://doi.org/10.1080/09638237.2017.1294735
  11. Bø, K. E., Halvorsen, K. H., Le, A. Y. N., & Lehnbom, E. C. (2024). Barriers and facilitators of pharmacists’ integration in a multidisciplinary home care team: a qualitative interview study based on the normalization process theory. BMC Health Services Research, 24(1), 567. https://doi.org/10.1186/s12913-024-11014-y
  12. Botes, M. (2025). Regulatory challenges of digital health: the case of mental health applications and personal data in South Africa. Frontiers in Pharmacology, 16, 1498600. https://doi.org/10.3389/fphar.2025.1498600
  13. Bronkhorst, E., Adamjee, M., & Poka, M. (2024). The misuse of codeine containing medicines: Perceptions and behaviours of qualified pharmacy professionals. South African Family Practice, 66(1), 5862. https://doi.org/10.4102/safp.v66i1.5862
  14. Calogero, S., & Caley, C. F. (2017). Supporting patients with mental illness: Deconstructing barriers to community pharmacist access. Journal of the American Pharmacists Association, 57(2), 248–255. https://doi.org/10.1016/j.japh.2016.12.066
  15. Chuene, T. A., & Moloto, N. B. (2023). The untapped skills of hospital pharmacists in South Africa: How can pharmacists improve service delivery in preparation. Global Health Management Journal,, 6, 71–80. https://doi.org/10.35898/ghmj-62964
  16. Crafford, L., Stoffels, M., Wagenaar, C., Bronkhorst, E., Gous, A., Kusurkar, R. A., & Wouters, A. (2025). Navigating Boundaries: How Pharmacists Develop Their Clinical Identity in a Complex Multidisciplinary Healthcare Setting. Perspectives on Medical Education, 14(1), 230. https://doi.org/10.5334/pme.1597
  17. Crespo-Gonzalez, C., Dineen-Griffin, S., Rae, J., & Hill, R. A. (2022). Mental health training programs for community pharmacists, pharmacy staff and students: A systematic review. Research in Social and Administrative Pharmacy, 18(11), 3895–3910. https://doi.org/10.1016/j.sapharm.2022.06.006
  18. Daliri, D. B., Afaya, A., Laari, T. T., Fredrick, A., Ankamah, A. G., Annan, S., & Abagye, N. (2023). Five-year trend of antipsychotic prescription practices in a district Hospital in Ghana: A retrospectivestudy. Neuropsychopharmacology Reports, 43(3), 434–439. https://doi.org/10.1002/npr2.12372
  19. Davis, B., Qian, J., Ngorsuraches, S., Jeminiwa, R., & Garza, K. B. (2020). The clinical impact of pharmacist services on mental health collaborative teams: A systematic review. Journal of the American Pharmacists Association, 60(5), S44–S53. https://doi.org/10.1016/j.japh.2020.05.006
  20. Dhindayal, S., Letsoalo, M. P., & Gengiah, T. N. (2022). Mental health outcomes and workplace quality of life among South African pharmacists during the COVID-19 pandemic: a cross-sectional study. Journal of Pharmaceutical Policy and Practice, 15(1), 66. https://doi.org/10.1186/s40545-022-00463-7
  21. Docrat, S., Besada, D., Cleary, S., Daviaud, E., & Lund, C. (2019). Mental health system costs, resources and constraints in South Africa: a national survey. Health policy and planning, 34(9), 706–719. https://doi.org/10.1093/heapol/czz085
  22. Eaves, S., Gonzalvo, J., Hamm, J. A., Williams, G., & Ott, C. (2020). The evolving role of the pharmacist for individuals with serious mental illness. Journal of the American Pharmacists Association, 60(5), S11–S14. https://doi.org/10.1016/j.japh.2020.04.017
  23. El-Den, S., Collins, J. C., Chen, T. F., & O’reilly, C. L. (2021). Pharmacists’ roles in mental healthcare: past, present and future. Pharmacy Practice (Granada), 19(3). https://doi.org/10.18549/pharmpract.2021.3.2545
  24. Emsley, R., Hawkridge, S., Potocnik, F. C., Seedat, S., Flisher, A. J., Stein, D. J., ... & Szabo, C. P. (2013). Introduction: The South African Society of Psychiatrists (SASOP) treatment guidelines for psychiatric disorders. South African Journal of Psychiatry, 19(3), 134–135. https://doi.org/10.4102/sajpsychiatry.v19i3.942
  25. Farag, M., Hoti, K., Hughes, J., & Chalmers, L. (2022). Impact of a clinical pharmacist on medication safety in mental health Hospital-in-the-Home: a retrospective analysis. International Journal of Clinical Pharmacy, 44(4), 947–955. https://doi.org/10.1007/s11096-022-01409-4
  26. Freeman, M. (2022). Investing for population mental health in low- and middle-income countries-where and why? International Journal of Mental Health Systems, 16(1), 38. https://doi.org/10.1186/s13033-022-00547-6
  27. Giannetti, V., Caley, C. F., Kamal, K. M., Covvey, J.R., McKee, J., Wells, B. G., ... & Vadagam, P. (2018). Community pharmacists and mental illness: a survey of service provision,stigma, attitudes and beliefs. International journal of clinical pharmacy, 40, 1096–1105. https://doi.org/10.1007/s11096-018-0619-7
  28. Goodman, C. S., Smith, T. J., & LaMotte, J. M. (2017). A survey of pharmacists’ perceptions of the adequacy of their training for addressing mental health–related medication issues. Mental Health Clinician, 7(2), 69–73. https://doi.org/10.9740/mhc.2017.03.069
  29. Gregory, A. T., & Denniss, A. R. (2018). An introduction to writing narrative and systematic reviews—Tasks, tips and traps for aspiring authors. Heart, Lung and Circulation, 27(7), 893–898. https://doi.org/10.1016/j.hlc.2018.03.02
  30. Groen, G., Jörns-Presentati, A., Dessauvagie, A., Seedat, S., Van den Heuvel, L. L., Suliman, S., ... & Lahti, M. (2022). Development of a mobile application for detection of adolescent mental health problems and feasibility assessment with primary health care workers. Issues in Mental Health Nursing, 43(11), 1046–1055. https://doi.org/10.1080/01612840.2022.2124003
  31. Hoppe, J., Howland, M. A., & Nelson, L. (2014). The role of pharmacies and pharmacists in managing controlled substance dispensing. Pain Medicine, 15(12), 1996–1998. https://doi.org/10.1111/pme.12531
  32. Howe, J., & Lindsey, L. (2023). The role of pharmacists in supporting service users to optimise antipsychotic medication. International Journal of Clinical Pharmacy, 45(5), 1293–1298. https://doi.org/10.1007/s11096-023-01630-9
  33. Iheanacho, C. O., Odili, V. U., & Oluigbo, K. E. (2021). Predominant sources of pharmacists’ drug information, and identification of drug information needs from pharmacists in community and hospital settings. Indian Journal of Pharmacy Practice, 14(1).
  34. Jacobs, Y., Myers, B., Van Der Westhuizen, C., Brooke-Sumner, C., & Sorsdahl, K. (2021). Task sharing or task dumping: counsellors experiences of delivering a psychosocial intervention for mental health problems in South Africa. Community Mental Health Journal, 57, 1082–1093. https://doi.org/10.1007/s10597-020-00734-0
  35. Kaminskiy, E., Zisman-Ilani, Y., Morant, N., & Ramon, S. (2021). Barriers and enablers to shared decision making in psychiatric medication management: A qualitative investigation of clinician and service users’ views. Frontiers in psychiatry, 12, 678005. https://doi.org/10.3389/fpsyt.2021.678005
  36. Kroenke, K., & Unutzer, J. (2017). Closing the false divide: sustainable approaches to integrating mental health services into primary care. Journal of general internal medicine, 32(4), 404–410. https://doi.org/10.1007/s11606-016-3967-9
  37. Lindsey, L., Husband, A., Steed, L., Walton, R., & Todd, A. (2017). Helpful advice and hidden expertize: pharmacy users’ experiences of community pharmacy accessibility. Journal of public health, 39(3), 609–615. https://doi.org/10.1093/pubmed/fdw089
  38. Lund, C., Petersen, I., Kleintjes, S., & Bhana, A. (2012). Mental health services in South Africa: Taking stock. African Journal of Psychiatry, 15(6), 402–405. https://doi.org/10.4314/ajpsy.v15i6.48
  39. Mahmud, S., Hossain, S., Muyeed, A., Islam, M. M., & Mohsin, M. (2021). The global prevalence of depression, anxiety, stress, and insomnia and its changes among health professionals during COVID-19 pandemic: A rapid systematic review and meta-analysis. Heliyon, 7(7). https://doi.org/10.1016/j.heliyon.2021.e07393
  40. Meyer, J. C., Matlala, M., & Chigome, A. (2019). Mental healthcare-a public health priority in South Africa. South African Family Practice, 61(5), 25–29. https://doi.org/10.4102/safp.v61i5.4946
  41. Moloto, N. B., Chuene, T. A., Makgopa, K. D., Mogano, K. M., Rakgoale, M. U., & Rekhotho, M. S. (2024). Barriers to Community Pharmacists’ Prescribing Role in Limpopo Province, South Africa: A Qualitative Study. Rwanda Journal of Medicine and Health Sciences, 7(2), 106–119. https://doi.org/10.4314/rjmhs.v7i2.1
  42. Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., ... & Sketris, I. (2015). From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health policy, 119(5), 628–639.
  43. Munisi, K. M., Rammutla, T. R., & Vagiri, R. V. (2020). Interventions to improve pharmacist counselling of mental healthcare patients at Weskoppies Hospital. SA Pharmaceutical Journal, 87(4), 45–48.
  44. Murphy, A. L., Phelan, H., Haslam, S., Martin-Misener, R., Kutcher, S. P., & Gardner, D. M. (2016). Community pharmacists’ experiences in mental illness and addictions care: a qualitative study. Substance abuse treatment, prevention, and policy, 11, 1–14. https://doi.org/10.1186/s13011-016-0050-9
  45. Naidoo, V., Suleman, F., & Bangalee, V. (2021). Roles and reimbursement of pharmacists as South Africa transitions towards Universal Health Coverage (UHC): an online survey-based study. Plos one, 16(9), e0257348. https://doi.org/10.1371/journal.pone.0257348
  46. Naslund, J. A., Aschbrenner, K. A., Araya, R., Marsch, L. A., Unützer, J., Patel, V., & Bartels, S. J. (2017). Digital technology for treating and preventing mental disorders in low-income and middle-income countries: a narrative review of the literature. The Lancet Psychiatry, 4(6), 486–500. https://doi.org/10.1016/s2215-0366(17)30096-2
  47. Ng, R., El-Den, S., Stewart, V., Collins, J. C., Roennfeldt, H., McMillan, S. S., ... & O’Reilly, C.L. (2022). Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review. Australian & New Zealand Journal of Psychiatry, 56(9), 1080–1103.https://doi.org/10.1177/00048674211048410
  48. Ng, R., El-Den, S., Collins, J. C., McMillan, S. S., Hu, J., Wheeler, A. J., & O’Reilly, C. L. (2024). Community pharmacists’ views and experiences of delivering in-pharmacy medication reviews for people living with severe and persistent mental illness: a qualitative study. International Journal of Clinical Pharmacy, 46(4), 862–871. https://doi.org/10.1007/s11096-024-01720-2
  49. O’Reilly, C. L., Bell, J. S., Kelly, P. J., & Chen, T. F. (2015). Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia. Research in Social and Administrative Pharmacy, 11(3), 101–109. https://doi.org/10.1016/j.sapharm.2013.04.006
  50. Petersen, I., & Lund, C. (2011). Mental health service delivery in South Africa from 2000 to 2010: One step forward, one step back. South African Medical Journal, 101(10), 751–757.
  51. Pope, E., McCullough, M., Smith, J. G., & Kim, B. (2024). Knowledge, practice and attitudes regarding substance use disorder treatment and harm reduction strategies among pharmacists: a scoping review protocol. BMJ open, 14(2). https://doi.org/10.1136/bmjopen-2023-080338
  52. Qin, X., & Hsieh, C. R. (2020). Understanding and addressing the treatment gap in mental healthcare: economic perspectives and evidence from China. INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 57, 0046958020950566. https://doi.org/10.1177/0046958020950566
  53. Richardson, T. E., O’Reilly, C. L., & Chen, T. F. (2014). A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. International journal of clinical pharmacy, 36, 222–232. https://doi.org/10.1007/s11096-013-9900-y
  54. Rotimi, K., Edeh, F. K., Aiden, J., Itiola, A. J., & Obamiro, K. (2022). Factors that influence pharmacists’ efforts in addressing substance use in Nigeria: An exploratory study. Exploratory Research in Clinical and Social Pharmacy, 8, 100189.https://doi.org/10.1016/j.rcsop.2022.100189
  55. Rubio-Valera, M., Chen, T. F., & O’Reilly, C. L. (2014). New roles for pharmacists in community mental healthcare: a narrative review. International journal of environmental research and public health, 11(10),10967–10990. https://doi.org/10.3390/ijerph111010967
  56. Rugkåsa, J., Tveit, O. G., Berteig, J., Hussain, A., & Ruud, T. (2020). Collaborative care for mental health: a qualitative study of the experiences of patients and health professionals. BMC Health Services Research, 20, 1–10. https://doi.org/10.1186/s12913-020-05691-8
  57. Samorinha, C., Saidawi, W., Saddik, B., Abduelkarem, A. R., Alzoubi, K. H., Abu-Gharbieh, E., & Alzubaidi, H. (2022). How is mental healthcare provided through community pharmacies? A quest for improvement. Pharmacy Practice, 20(2), 2648. https://doi.org/10.18549/pharmpract.2022.2.2648
  58. Saraiva, S., Bachmann, M., Andrade, M., & Liria, A. (2020). Bridging the mental health treatment gap: effects of a collaborative care intervention (matrix support) in the detection and treatment of mental disorders in a Brazilian city. Family Medicine and Community Health, 8(4), e000263. https://doi.org/10.1136/fmch-2019-000263
  59. Schuch, F. B., & Vancampfort, D. (2021). Physical activity, exercise, and mental disorders: it is time to move on. Trends in psychiatry and psychotherapy, 43(3), 177–184. https://doi.org/10.47626/2237-6089-2021-0237
  60. Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2020). Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Systematic reviews, 9, 1–18. https://doi.org/10.1186/s13643-020-1274-3
  61. Silverio, S. A., Rahman, M. R., Wilson, C. A., Catalao, R., Lakhani, S., Alter, M., ... & Flynn, A.C. (2023). “There’s very little that you can do other than refer them to the doctor if you think they’ve got postnatal depression”: Scoping the potential for perinatal mental healthcare by community pharmacists. Research in Social and Administrative Pharmacy, 19(2), 286–292.
  62. Snyder, M. E., Earl, T. R., Gilchrist, S., Greenberg, M., Heisler, H., Revels, M., & Matson-Koffman, D. (2015). Collaborative drug therapy management: case studies of three community-based models of care. Preventing Chronic Disease, 12, E39. https://doi.org/10.5888/pcd12.140504
  63. Syrnyk, M., & Glass, B. (2023). Pharmacist interventions in medication adherence in patients with mental health disorders: a scoping review. International Journal of Pharmacy Practice, 31(5), 449–458. https://doi.org/10.1093/ijpp/riad037
  64. Thornicroft, G., Sunkel, C., Aliev, A. A., Baker, S., Brohan, E., El Chammay, R., ... & Winkler, P. (2022). The Lancet Commission on ending stigma and discrimination in mental health. The Lancet, 400(10361), 1438–1480. https://doi.org/10.1016/s0140-6736(22)01470-2
  65. Venetia, N., Evangelia, S., Christina, D., Evanthia, S., & Areti, L. (2022). Pharmacists’ Knowledge, Attitudes and Practices Towards People with Mental Health Problems: A Cross-Sectional Study. International Journal of Caring Sciences, 15(3), 1904–1911.
  66. Wainberg, M. L., Scorza, P., Shultz, J. M., Helpman, L., Mootz, J. J., Johnson, K. A., ... & Arbuckle, M. R. (2017). Challenges and opportunities in global mental health: a research-to-practice perspective. Current psychiatry reports, 19, 1–10. https://doi.org/10.1007/s11920-017-0780-z
  67. Werremeyer, A., Bostwick, J., Cobb, C., Moore, T. D., Park, S. H., Price, C., & McKee, J. (2020). Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Mental Health Clinician, 10(6), 358–380. https://doi.org/10.9740/mhc.2020.11.358
  68. Wheeler, A. J., O’Reilly, C. L., El-Den, S., Byrnes, J., Ware, R. S., & McMillan, S. S. (2020). Bridging the gap between physical and mental illness in community pharmacy (PharMIbridge): protocol for an Australian cluster randomised controlled trial. BMJ open, 10(7), e039983. https://doi.org/10.1136/bmjopen-2020-039983
  69. World Health Organization. (2007). Everybody’s business: Strengthening health systems to improve health outcomes. WHO’s framework for action. Geneva: WHO Press.
  70. World Health Organization. (2023). Integrating Mental Health in Primary Health Care: Part 1. The Context for Integration of Mental Health Services in Primary Health Care; Regional Office for the Eastern Mediterranean: Cairo, Egypt, 2023. Licence: CC BY-NC-SA 3.0 IGO.
  71. World Health Organization. (2018). Mental Disorders: Key Facts; World Health Organization: Geneva, Switzerland, 2018
Language: English
Page range: 183 - 197
Submitted on: Jun 19, 2025
Accepted on: Oct 31, 2025
Published on: Nov 10, 2025
Published by: International Platform on Mental Health
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Tiisetso Aubrey Chuene, published by International Platform on Mental Health
This work is licensed under the Creative Commons Attribution 4.0 License.